These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8640298)

  • 1. Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats.
    Wentzel P; Eriksson UJ
    Eur J Endocrinol; 1996 Apr; 134(4):459-66. PubMed ID: 8640298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic teratogenesis. In vitro evidence for a multifactorial etiology with little contribution from glucose per se.
    Buchanan TA; Denno KM; Sipos GF; Sadler TW
    Diabetes; 1994 May; 43(5):656-60. PubMed ID: 8168642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of rat embryos in culture media containing different concentrations of normal and diabetic rat serum.
    Styrud J; Eriksson UJ
    Teratology; 1992 Nov; 46(5):473-83. PubMed ID: 1462252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E.
    Viana M; Herrera E; Bonet B
    Diabetologia; 1996 Sep; 39(9):1041-6. PubMed ID: 8877287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture.
    Wentzel P; Thunberg L; Eriksson UJ
    Diabetologia; 1997 Jan; 40(1):7-14. PubMed ID: 9028712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of interrupted insulin treatment on fetal outcome of pregnant diabetic rats.
    Eriksson RS; Thunberg L; Eriksson UJ
    Diabetes; 1989 Jun; 38(6):764-72. PubMed ID: 2656344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between maternal metabolism and deranged development in the offspring of normal and diabetic rats.
    Styrud J; Thunberg L; Nybacka O; Eriksson UJ
    Pediatr Res; 1995 Mar; 37(3):343-53. PubMed ID: 7784144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for multifactorial origin of diabetes-induced embryopathies.
    Sadler TW; Hunter ES; Wynn RE; Phillips LS
    Diabetes; 1989 Jan; 38(1):70-4. PubMed ID: 2909414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos.
    Eriksson UJ; Borg LA
    Diabetes; 1993 Mar; 42(3):411-9. PubMed ID: 8432412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGE2 prevents anomalies induced by hyperglycemia or diabetic serum in mouse embryos.
    Goto MP; Goldman AS; Uhing MR
    Diabetes; 1992 Dec; 41(12):1644-50. PubMed ID: 1446806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo.
    Lee AT; Reis D; Eriksson UJ
    Diabetes; 1999 Feb; 48(2):371-6. PubMed ID: 10334316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring.
    Eriksson UJ; Simán CM
    Diabetes; 1996 Nov; 45(11):1497-502. PubMed ID: 8866552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of congenital malformations in diabetic pregnancy.
    Eriksson UJ; Karlsson MG; Styrud J
    Biol Neonate; 1987; 51(2):113-8. PubMed ID: 3552057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation diminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro.
    Wentzel P; Gäreskog M; Eriksson UJ
    Diabetes; 2005 Feb; 54(2):546-53. PubMed ID: 15677514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos.
    Wentzel P; Ejdesjö A; Eriksson UJ
    Diabetes; 2003 May; 52(5):1222-8. PubMed ID: 12716756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of diabetic embryopathy in offspring of diabetic rats with use of a cocktail of deficient substrates and an antioxidant.
    Reece EA; Wu YK
    Am J Obstet Gynecol; 1997 Apr; 176(4):790-7; discussion 797-8. PubMed ID: 9125602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Acetylcysteine and alpha-cyano-4-hydroxycinnamic acid alter protein kinase C (PKC)-delta and PKC-zeta and diminish dysmorphogenesis in rat embryos cultured with high glucose in vitro.
    Gäreskog M; Wentzel P
    J Endocrinol; 2007 Jan; 192(1):207-14. PubMed ID: 17210758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity.
    Wentzel P; Wentzel CR; Gäreskog MB; Eriksson UJ
    Teratology; 2001 May; 63(5):193-201. PubMed ID: 11320530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A diabetes-like environment increases malformation rate and diminishes prostaglandin E(2) in rat embryos: reversal by administration of vitamin E and folic acid.
    Wentzel P; Eriksson UJ
    Birth Defects Res A Clin Mol Teratol; 2005 Jul; 73(7):506-11. PubMed ID: 15959876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and environmental influence on diabetic rat embryopathy.
    Ejdesjö A; Wentzel P; Eriksson UJ
    Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E454-67. PubMed ID: 21119026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.